Dr. Reddy’s launches nystatin/triamcinolone acetonide cream

HYDERABAD, India and PRINCETON, N.J. — Dr. Reddy’s Laboratories on Monday announced the U.S. launch of its nystatin and triamcinolone acetonide cream (USP 1000,0000 units/g — 0.1%), a generic equivalent of the same cream made by Taro Pharmaceuticals USA. 

 

The drug had $119 million in sales for the 12 months ended October 2016, according to QuintilesIMS data. The cream is available in tube sizes of 15, 30 and 60 grams.